Article citationsMore>>

R. Muga, K. Langohr, J. Tor, A. Sanvisens, I. Serra and C. R. Rey-Joly, “Survival of HIV-Infected Injection Drug Users (IDUs) in the Highly Active Antiretroviral Therapy Era, Relative to Sex- and Age-Specific Survival of HIV-Un- infected IDUs,” Clinical Infectious Diseases, Vol. 45, No. 3, 2007, pp.370-376. doi:10.1086/519385

has been cited by the following article:

• TITLE: Estimating the Size of an Injecting Drug User Population

  AUTHORS: Yang Zhao

  KEYWORDS: Injecting Drug Users, Needle Exchange Programs, Respondent-Driven Sampling, Estimating the Size of an IDU Population

  JOURNAL NAME: World Journal of AIDS, Vol.1 No.3, September 29, 2011

  ABSTRACT: This article describes a sampling and estimation scheme for estimating the size of an injecting drug user (IDU) population by combining classical sampling and respondent-driven sampling procedures. It is designed to use the information from harm reduction programs, especially, Needle Exchange Programs (NEPs). The approach involves using respondent-driven sampling design to collect a sample of injecting drug users who appear at site of NEP in a certain period of time and to obtain retrospective self-report data on the number of friends among the IDUs and number of needles exchanged for each sampled injecting drug user. A methodology is developed to estimate the size of injecting drug users who have ever used the NEP during the fixed period of time, and which allows us to estimate the proportion of injecting drug users in using NEP. The size of the IDU population is estimated by dividing the total number of IDUs who using NEPs during the period of time by the estimated proportion of IDUs in the group. The technique holds promise for providing data needed to answer questions such as “What is the size of an IDU population in a city?” and “Is that size changing?” and better understand the dynamics of the IDU population. The methodology described here can also be used to estimate size of other hard-to-reach population by using information from harm reduction programs.